Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 55981-09-4
Drug Levels and Effects
Summary of Use during Lactation
Limited information indicates that a maternal dose of 500 mg of nitazoxanide produces low levels of an active metabolite, tizoxanide, in breastmilk and would not be expected to cause any adverse effects in breastfed infants, especially if the infant is older than 2 months. But until more data become available, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
Drug Levels
After oral administration, nitazoxanide is not found in the bloodstream, but is rapidly converted to the active metabolites, tizoxanide and tizoxanide glucuronide, which are detectable in plasma.
Maternal Levels. A volunteer lactating mother took a single 500 mg oral dose of nitazoxanide as a commercial suspension (Nitazode, Al Andalous Medical Co., Cairo, Egypt). The concentration of the active metabolite, tizoxanide, was 1.4 mg/L at 6 hours after the dose. Tizoxanide glucuronide was not measured.[1]
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
References
- 1.
- Hadad GM, Abdel Salam RA, Emara S. Validated and optimized high-performance liquid chromatographic determination of tizoxanide, the main active metabolite of nitazoxanide in human urine, plasma and breast milk. J Chromatogr Sci. 2012;50:509–15. [PubMed: 22525879]
Substance Identification
Substance Name
Nitazoxanide
CAS Registry Number
55981-09-4
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- LactMed App
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Diclofenac.[Drugs and Lactation Database (...]Review Diclofenac.. Drugs and Lactation Database (LactMed®). 2006
- Review Nizatidine.[Drugs and Lactation Database (...]Review Nizatidine.. Drugs and Lactation Database (LactMed®). 2006
- Review Acebutolol.[Drugs and Lactation Database (...]Review Acebutolol.. Drugs and Lactation Database (LactMed®). 2006
- Review Nitrazepam.[Drugs and Lactation Database (...]Review Nitrazepam.. Drugs and Lactation Database (LactMed®). 2006
- Review Prilocaine.[Drugs and Lactation Database (...]Review Prilocaine.. Drugs and Lactation Database (LactMed®). 2006
- Nitazoxanide - Drugs and Lactation Database (LactMed®)Nitazoxanide - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...